IL33 and airway hyperresponsiveness: Several cytokines are now known to be key regulators of events that can lead to the development of airway hyperresponsiveness (AHR) and chronic inflammation, including IL-18, IL-25, IL-33 and thymic stromal lymphopoietin (TSLP), all of which are released by epithelial cells [4, 5].